ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The specialty ingredient firm Balchem will acquire Kappa Bioscience, a Norwegian maker of vitamin K₂, for about $338 million. Based in New Hampton, New York, Balchem produces the animal nutrition ingredient choline chloride and chelated minerals for human health. The company says entering the vitamin K₂ business fits its strategy of expanding in the specialty nutrient field.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter